Hugo RAS机器人子宫肌瘤剔除术的安全高效操作演示
本文以手术视频形式报告1例41岁未育女性多发性子宫肌瘤患者,采用Hugo RAS机器人系统行保留生育功能的子宫肌瘤剔除术,主病灶为5.5 cm FIGO 2型前壁肌瘤。手术采用低腹壁穿刺孔布局、双侧子宫动脉临时阻断及肌层内加压素注射止血,手术时间122 min,估计出血量50 mL,无并发症。
要点
- Hugo RAS系统可使用标准腹腔镜穿刺器,三臂完成机器人子宫肌瘤剔除。
- 低腹壁穿刺孔布局改善美容效果,但不适合较大子宫。
- 术中行双侧子宫动脉临时阻断联合肌层内加压素注射控制出血。
核心结论
- Hugo RAS平台机器人子宫肌瘤剔除术在该选择病例中表现可行且安全,目前尚无比较研究支持其优于其他机器人系统。
研究设计与样本
- 手术视频演示(病例报告),单中心(巴西圣保罗Einstein Hospital Israelita),1例41岁未育女性。
主要发现
- 子宫体积202 cm³,主病灶为5.5 cm FIGO 2型前壁肌瘤。
- 手术时间122 min,估计出血量50 mL,无并发症。
- 较小肌瘤未予切除,以避免不必要的肌层损伤。
关键数值与推荐
- 采用三个机器人臂和标准腹腔镜穿刺器,系统无需专用穿刺器。
- 止血方法为双侧子宫动脉临时阻断加肌层内加压素注射,使用单极和双极能量。
- 标本经阴道保护袋取出,选择性未育患者可考虑密闭冷刀旋切。
- 低腹壁穿刺孔布局可能不适合较大子宫。
临床怎么用
- 对合适大小和位置的肌瘤,可参考本视频的穿刺孔布局、止血策略和多层缝合技术开展Hugo RAS机器人子宫肌瘤剔除术。
局限性
- 仅为单例病例报告,无对照或比较数据,不能证明优于其他机器人系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To describe a safe and efficient approach for robotic myomectomy using the Hugo RAS system, emphasizing aesthetic trocar positioning, optimized hemostatic strategies, and precise uterine reconstruction in a fertility-preserving setting. DESIGN: Surgical video demonstration (case report). SETTING: Referral center (Einstein Hospital Israelita, São Paulo, Brazil), with active use of the Hugo RAS platform in gynecologic surgery. PARTICIPANTS: A 41-year-old nulliparous woman with abnormal uterine bleeding and infertility desiring future fertility. Magnetic resonance imaging revealed an enlarged uterus (202 cm³) with multiple fibroids. The dominant lesion was a 5.5 cm FIGO type 2 anterior fibroid. Smaller fibroids did not distort the uterine cavity and were not removed to avoid unnecessary myometrial injury. INTERVENTIONS: Robotic myomectomy was performed using three robotic arms and standard laparoscopic trocars, as the system does not require proprietary ports [1]. The approach was selected based on favorable fibroid size and location. Although robotic assistance is not indispensable, it may facilitate precise multilayer suturing and effective hemostatic control in fertility-preserving surgery. Low abdominal port placement was adopted for improved cosmetic results, acknowledging that this configuration may not be suitable for larger uteri. Hemostasis included temporary bilateral uterine artery clipping and intramyometrial vasopressin injection. Monopolar and bipolar energy were used. Specimen extraction was performed transvaginally using a protective bag; alternatively, contained cold-scalpel morcellation techniques may be considered in selected nulliparous patients. Operative time was 122 min, with 50 mL estimated blood loss and no complications [2]. CONCLUSION: Robotic myomectomy with the Hugo™ RAS platform showed feasible and safe performance in this selected case. There are currently no comparative studies supporting superiority over other robotic systems. VIDEO ABSTRACT.
引用
- Arcas GM, Lottenberg CP, Maranhao DDA, et al. Robotic Myomectomy Using Hugo RAS Platform: a Step-by-Step on how to be Safe and Efficient. J Minim Invasive Gynecol. 2026. PMID: 41825812. doi:10.1016/j.jmig.2026.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。